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ABSTRACT 
 
Acute effects of ghrelin on excitatory synaptic transmission were evaluated on hippocampal 
CA1 synapses. Ghrelin triggered an enduring enhancement of synaptic transmission 
independently of NMDA receptor activation and likely via postsynaptic modifications. This 
ghrelin-mediated potentiation resulted from the activation of GHS-R1a receptors as it was 
mimicked by the selective agonist JMV1843 and blocked by the selective antagonist 
JMV2959. This potentiation also required the activation of PKA and ERK pathways to occur 
since it was inhibited by KT5720 and U0126, respectively. Moreover it most likely involved 
Ca
2+
 influxes as both ghrelin and JMV1843 elicited intracellular Ca
2+
 increases, which were 
dependent on the presence of extracellular Ca
2+ 
and mediated by L-type Ca
2+ 
channels 
opening. In addition, ghrelin potentiated AMPA receptor-mediated [Ca
2+
]i increases while 
decreasing NMDA receptor-mediated ones. Thus the potentiation of synaptic transmission by 
GHS-R1a at hippocampal CA1 excitatory synapses likely results from postsynaptic 
mechanisms involving PKA and ERK activation, which are producing long-lasting 
enhancement of AMPA receptor-mediated responses. 
 
INTRODUCTION  
 
The orexigenic hormone ghrelin, a 28 amino acid octanoylated peptide, was first described 
as an endogenous peptide predominantly synthetized by the empty stomach, activating 
hypothalamic neurons responsible for food intake and regulation of energy balance 
(Andrews, 2011). Beside these well-established functions, several reviews mentioned that 
ghrelin is also associated with the regulation of several brain activities including reward, drug 
seeking, ethanol addiction, and memory storage (Dickson et al., 2011; Isokawa, 2012). It thus 
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provides an interesting link between the central nervous system and the enteric nervous 
system, so-called ‘the second brain’. Moreover, ghrelin exhibits numerous beneficial actions 
against neurotoxic challenges such as 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure 
(Jiang et al., 2008) or amyloid--1-42 oligomer-induced neurodegeneration (Moon et al., 
2011). It also prevents amnesia produced by exposure to the N-Methyl-D-Aspartate (NMDA) 
receptor antagonist dizolcipine (MK801) (Goshadrou et al., 2013). 
Ghrelin affects brain activity by binding the growth hormone secretagogue receptor 1a 
(GHS-R1a), a G protein coupled receptor. GHS-R1a is densely expressed in the 
hypothalamus, the substantia nigra, the ventral tegmental area (VTA) and throughout the 
limbic system, including the hippocampus. The activation of GHS-R1a enhances neuronal 
excitability as demonstrated recently in the substantia nigra pars compacta and CA1 area of 
the hippocampus (Shi et al., 2013). This increase in excitability could explain the ghrelin-
induced increases of dopamine in the nucleus accumbens (Jerlhag et al., 2006) and of 
acetylcholine in the VTA (Jerlhag et al., 2012). 
Furthermore, the contribution of constitutively active GHS-R1a receptors to 
neurophysiological processes is supported by several studies (Pantel et al., 2006; Pazos et al., 
2008; Portelli et al., 2012). 
GHS-R1a is markedly expressed in the hippocampus (Guan et al., 1997), an essential area 
for learning and memory. Local infusions of ghrelin induce strong pro-mnesic effects as 
evidenced by spatial memory tests (Diano et al., 2006; Atcha et al., 2009; Carlini et al., 2010; 
Chen et al., 2011). Since long-term potentiation (LTP) is considered as the 
neurophysiological substrate of memory formation in the CA1 area of the hippocampus 
(Lynch, 2004), positive effects of ghrelin on synaptic transmission, and most particularly on 
high frequency-induced LTP, are expected. Consistently, enhancements (Diano et al., 2006; 
Ribeiro et al., 2014), or facilitation (Carlini et al., 2010) of LTP elicited by ghrelin are 
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observed, either using acute hippocampal slice preparations or organotypic cultures. In 
addition, in vivo experiments in the dentate gyrus show that the application of ghrelin could 
by itself induce a long-lasting increase in excitatory transmission, while having a positive 
effect only on the maintenance of high frequency-evoked LTP but not on its induction (Chen 
et al., 2011). These effects of ghrelin likely involve a delayed stimulation of the 
phosphoinositide-3-kinase (PI3K) and of the extracellular signal-regulated kinases (ERK) 
pathways (Chen et al., 2011). 
Therefore, we have characterized here the effect of the direct stimulation of GHS-R1a on 
synaptic transmission in the CA1 area of the hippocampus using selective agonists, i.e. 
octanoylated-ghrelin and a synthetic analog, JMV1843 (Guerlavais et al., 2003), along to the 
use of a selective antagonist, JMV2959 (Moulin et al., 2007), in order to characterize these 
responses. Furthermore, as GHS-R1a could raise neuronal excitability by promoting 
intracellular Ca
2+
 ([Ca
2+
]i) increases via the coupling to Gq and phospholipase C (PLC) 
activation, the effect of GHS-R1a agonists was also evaluated on the [Ca
2+
]i in cultured 
hippocampal neurons. 
 
MATERIAL AND METHODS 
Experiments were conducted on acute rat hippocampal slices and cultured rat hippocampal 
neurons. 
Animals 
All experiments were carried out in accordance with the European Community Council 
Directive of September 22, 2010 (2010/63/UE). This study was approved by the local section 
of the ‘Comité National de Réflexion Ethique sur l’Expérimentation Animale’ (C2EA-36). 
All efforts were made to minimize animal suffering and to reduce the number of rats used. 
Sprague–Dawley rats were from the Centre d’Elevage Depré (France). 
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Materials and drugs 
Culture media (DMEM/Ham F12 with Hepes and 4.5 g/l glucose), Dulbecco’s phosphate-
buffered saline (Dulbecco’s PBS), Versene™, antibiotics, and fetal calf serum (FCS) were 
purchased from Invitrogen. Culture dishes were from Nunc.  
Ghrelin, D-Amino-phosphonovalerate (AP5) and di-hydroxy-phenyl-glycine (DHPG) were 
purchased from Abcam Biochemicals. KT-5720, kainate and NMDA were obtained from 
Sigma and U0126 from Euromedex. KT-5720 and U0126 were used at the efficient 
concentration recommended by the manufacturer. JMV1843 and JMV2959 were synthesized 
in the laboratory, and used at efficient doses previously determined (Mousseaux et al., 2006; 
Moulin et al., 2013). 
 
Hippocampal slice preparation 
Hippocampal slices (300 µm) were obtained from male Sprague-Dawley rats. After 
decapitation, brains were quickly dissected and placed in ice-cold buffer comprising 124 mM 
NaCl, 3.5 mM KCl, 25 mM NaHCO3, 1.25 mM NaH2PO4, 1 mM CaCl2, 2 mM MgSO4, 
10 mM D-glucose, and 10 mM HEPES bubbled with O2/CO2 (95%/5%). Slices were then cut 
with a Vibratome (VT1000S; Leica, France) and maintained at room temperature for at least 
1 h in the same buffer supplemented with 1 mM CaCl2. This supplemented buffer – also 
named extracellular medium – was used for further recordings. 
 
Electrophysiological recordings with micro-electrode array (MEA) 
For electrophysiological recordings, slices were transferred to an MEA (MEA60; Multi 
Channel Systems, Reutlingen, Germany) continually superfused with the above described 
extracellular medium (flow rate 2 ml.min
−1
) and kept at 32°C. Drugs were directly applied in 
this superfusion. MEA was positioned on the platform of a Leica inverted microscope 
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equipped with a CCD camera (CoolSnap, Roper Scientific, France). Images of the 
hippocampal slice on the MEA were captured in order to accurately map the synaptic signals 
recorded in the brain slice. MEA comprised 60 extracellular electrodes (Lante et al., 2008): 
The inter-electrode distance was 200 μm and each individual electrode from the array could 
be used either as a recording or as a stimulatory electrode. A nylon mesh was positioned 
above the slice to obtain a satisfactory electrical contact between the surface of the slice and 
the electrode array. Stimulation was achieved with an external stimulator (STG-1004; Multi 
Channel Systems) by applying biphasic current pulses to one electrode of the array, located in 
the Schaffer Collateral pathway of the hippocampus. Stimulation intensity (50 to 200 μA) and 
duration (70 to 200 μs) were adapted to avoid multiphasic responses due to excessive 
stimulation (Heuschkel et al., 2002). Field excitatory postsynaptic potentials (fEPSPs) could 
then be recorded by all the remaining electrodes of the array at the same time. Signals were 
recorded and analyzed (MC Rack; Multi Channel Systems). Baseline synaptic signals were 
evoked using 0.066 Hz frequency stimulation. Slices displaying epileptic-like activity were 
discarded. Data are presented as means ± SEM on graphs plotting pooled data. They are 
expressed as fEPSP amplitudes normalized to their corresponding baseline amplitudes. Each 
individual (‘n’) corresponds to an experiment performed on a slice from an individual animal. 
 
Primary cultures of rat hippocampal neurons 
Primary neuronal cultures were established from 18-day-old embryonic rat hippocampi, as 
previously described (Blanc et al., 1999; de Jesus Ferreira et al., 2005), with minor 
modifications. After pre-incubation with Versene™, hippocampal cells were mechanically 
dissociated and plated at a density of 2 × 10
6
 cells/dish in 8-well dishes containing glass 
coverslips. Culture dishes and coverslips have been previously coated with poly-L-lysine 
(15 μg/mL) and then with DMEM/HAM F12 containing 10% FCS. Cells were grown in a 
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defined medium containing DMEM/HAM F12, supplemented with 33 mM glucose, 2 mM 
glutamine, 100 U/mL penicillin, 100 μg/mL streptomycin, 13 mM sodium bicarbonate, 
50 μg/mL transferrin, 0.5 μg/mL insulin, 1 pM β-estradiol, 3 nM triiodothyronine, 20 nM 
progesterone, 46 nM sodium selenite, and 100 μM putrescine. All experiments were 
performed on cell cultures grown for at least 7 days in vitro. 
 
Measurements of cytosolic-free Ca
2+
 concentration 
Intracellular calcium concentration ([Ca
2+
]i) was measured with the fluorescent indicator 
fura-2 (Crouzin et al., 2007). For this purpose, hippocampal cells grown on square 
(10 × 10 mm) glass coverslips were loaded with fura-2 by a 30-min incubation at 37 °C with 
5 μM fura-2-AM and 0.02% Pluronic® in the extracellular solution: 124 mM NaCl, 
3.5 mM KCl, 25 mM NaHCO3, 1.25 mM NaH2PO4, 2 mM CaCl2, 2 mM MgSO4, 10 mM 
D-Glucose and 10 mM HEPES (bubbled with O2/CO2: 95/5) pH 7.4. [Ca
2+
]i was monitored 
by videomicroscopy. After rinsing, the glass coverslip was transferred to the recording 
chamber mounted on an inverted microscope (Leica, DMIRB). Fura-2 emission was obtained 
by exciting alternatively at 340 and 380 nm with a rotating filter wheel (Sutter Instruments) 
and by monitoring fluorescent emissions (F340 and F380) at 510 nm. The ratio of emissions 
at 510 nm (F340/F380) was recorded every 2 s. Fluorescent signals were collected with a 
CCD camera (Hamamatsu), digitized, and analyzed with image analysis software 
(Acquacosmos, Hamamatsu). Throughout recordings, coverslips were continually superfused 
with the extracellular solution thermostated at 37 °C. Some experiments were performed 
while omitting Ca
2+
 in the extracellular medium (‘Ca2+-free’ medium). Drug application was 
performed with a gravity-fed system. The ‘n’ values represent the entire population of cells 
recorded in at least 3 independent cultures. On the graphs, data are presented as 
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averages ± S.E.M. of fura2 fluorescence ratios obtained in individual cells. Ratios have been 
normalized to their respective baseline value measured prior to any treatment. 
 
Statistics 
All statistical analyses were performed using SigmaStat software (SigmaPlot 12.0, Systat 
Software, San Jose, CA) and the level of significance was settled at P < 0.05. Data are 
presented as means ± SEM. 
One-way analyses of variance followed by Bonferroni method for multiple comparisons 
were used to test the significance of the level of synaptic potentiation elicited by ghrelin or 
JMV1843. Two-way analyses of variance followed by Holm-Sidak method for multiple 
comparisons were used to test the significance of the effect of various drugs on these 
responses. 
For the analyses of calcium transients, areas above peaks in each individual cell were 
estimated using SigmaPlot software. Values were then compared using either one-way 
ANOVA on repeated measures for dose-response experiments, or using t-test for comparing 
two experimental conditions. Finally, the statistical significance of the difference between 
[Ca
2+
]i rises elicited by glutamatergic agonists in control and treated cells was evaluated by 
performing a two-way ANOVA on repeated measured followed by Holm-Sidak method for 
multiple comparisons. 
 
RESULTS 
The application of ghrelin (concentration range: 1-100 nM for 20 min; n = 9 each) elicited 
an enduring potentiation of the excitatory transmission between Schaffer collaterals and CA1 
neurons, which was maintained at least 50 min following ghrelin washout (Figure 1A). The 
effect of ghrelin was concentration-dependent (F2,6866 = 441, P < 0.001). It was significantly 
A
cc
ep
te
d 
A
rt
ic
le
 
This article is protected by copyright. All rights reserved. 
enhanced (P < 0.0001) as ghrelin concentration increased from 1 nM to 10 nM in the 
superfusion medium, but was not significantly different (P = 0.99) when using a further 
10-fold higher concentration (Figure 1A). For subsequent experiments, ghrelin was applied at 
a concentration of 10 nM. Under these conditions, 50 min after ghrelin washout, the fEPSP 
mean amplitude reached 158 ± 4 % of control amplitude. The paired-pulse facilitation ratios, 
obtained by applying two pulses separated by 50 ms interval, were 1.22 ± 0.05 (n = 5) prior 
to ghrelin (10 nM) application and 1.21 ± 0.04 (n = 5) once a stable potentiation had taken 
place (Figure 1B). These values were not significantly different (P = 0.29), suggesting that 
the ghrelin-induced synaptic potentiation most likely occurred via postsynaptic mechanisms. 
Then we verified that the ghrelin-induced potentiation occurred via the activation of GHS-
R1a. For this, the effect of JMV2959, a selective GHS-R1a antagonist, was tested at a 
concentration which blocked the biological responses elicited by 10 nM ghrelin (Moulin et 
al., 2013). In the presence of JMV2959 (100 nM), the effect of ghrelin (10 nM) was 
completely blocked (F1,4372 = 1219, P < 0.001 when comparing ghrelin responses either in the 
absence or the presence of JMV2959; Figure 2A). It is noticeable that JMV2959 had no per 
se effect on synaptic transmission. Moreover the selective GHS-R1a agonist, JMV1843 
(100 nM), also triggered a robust and long-lasting enhancement of synaptic transmission (n = 
9, P < 0.001 as compared to basal transmission) (Figure 2B). At the concentration tested, 
JMV 1843 is known to produce maximal effect on GHS-R1a (Mousseaux et al., 2006). 
Fifty min after JMV1843 washout, the fEPSP mean amplitude reached 148 ± 10 % of 
control amplitude (P < 0.002, as compared to basal). The JMV1843-induced synaptic 
potentiation was also blocked by JMV2959 (both drugs at 100 nM, n = 5; data not shown). 
Next, the dependence on NMDA receptor activation of ghrelin-induced potentiation of 
fEPSP was tested. To this aim, AP5 (25 µM; n = 9), a selective NMDA receptor antagonist, 
was applied prior to ghrelin. Under these conditions, the potentiating action of ghrelin was 
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significantly enhanced (F1,4985 = 751, P < 0.001, as compared to the effect of ghrelin in the 
absence of AP5) and fEPSP mean amplitude reached 240 ± 40 % of control amplitude 50 min 
after ghrelin wash-out (P = 0.029 as compared to basal; Figure 3). Similar data were obtained 
when GHS-R1a were activated by JMV1843 (not shown). 
The recruitment of intracellular pathways to mediate long-lasting synaptic changes was 
then further evaluated. In this line, we previously demonstrated that the stimulation of the 
cAMP/PKA pathway was central to synaptic potentiation and did not require NMDA receptor 
activation (Lante et al., 2006). The application of the selective PKA inhibitor, KT5720 
(250 nM), efficiently fully prevented the ghrelin-mediated synaptic potentiation (F1,3965 = 
953, P < 0.001, when comparing the effects of ghrelin either in the absence or the presence of 
KT5720; Figure 4A). In the presence of KT5720, ghrelin did not elicit any significant 
modification of synaptic transmission (P = 0.085, as compared to basal transmission). We 
then verified whether the MAP-kinase pathway, activated after PKA stimulation, could also 
be involved in ghrelin effect on synaptic transmission. For this, the ERK kinase inhibitor 
U0126 (10 µM) was tested. This inhibitor also significantly prevented the ghrelin-elicited 
synaptic potentiation (F1,4849 = 1082, P < 0.001, when comparing the effects of ghrelin in the 
absence or the presence of U0126; Figure 4B). Taken together, these data indicate that 
ghrelin-induced synaptic potentiation results from the activation of GHS-R1a followed by the 
stimulation of both cAMP/PKA and MAP-kinase pathways. 
GHS-R1a may couple the phospholipase C (PLC) pathway thus triggering intracellular 
Ca
2+
 mobilization after IP3 production (Mousseaux et al., 2006; Shi et al., 2013). We have 
thus evaluated the impact of ghrelin and JMV1843 on [Ca
2+
]i in cultured hippocampal 
neurons. Both ghrelin (Figure 5A) and JMV1843 (Figure 5B) elicited concentration-
dependent increases in [Ca
2+
]i (P = 0.002 and P < 0.001, respectively). Ghrelin significant 
effects were detected from a 1 nM concentration (P = 0.008, as compared to basal) and 
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reached maximal amplitude at 100 nM. In order to test whether ghrelin- and JMV1843-
mediated increases in [Ca
2+
]i effectively resulted from the mobilization of [Ca
2+
]i from IP3-
sensitive internal stores, experiments were carried out in Ca
2+
-free extracellular medium. 
Under these conditions, ghrelin induced changes in [Ca
2+
]i were strongly reduced (P 
= 0.0039 and P = 0.002 for the comparison of the effect of ghrelin 10 nM and 100 nM, 
respectively, in the presence of the absence of extracellular calcium; Figure 5C). Moreover, 
JMV1843 (100 nM) was unable to induce any significant [Ca
2+
]i response (P = 0.44 versus 
basal, P = 0.007, as compared to the effect of JMV1843, in the presence of extracellular 
calcium; Figure 5D). By contrast, under the same experimental conditions, the metabotropic 
glutamate 1/5 receptor agonist DHPG still triggered robust [Ca
2+
]i transients (P < 0.001, as 
compared to basal; Figures 5C and 5D). GHS-R1a activation thus mainly produced 
intracellular Ca
2+
 increase in hippocampal neurons by promoting Ca
2+
 influx from the 
extracellular medium. In our hands, L-type VGCC largely mediates the Ca
2+
 influxes 
observed after depolarization in hippocampal cultures (Pringos et al., 2012). Thus, verapamil, 
a L-type VGCC blocker was tested. In the presence of verapamil (50 µM), the ghrelin-
induced [Ca
2+
]i increase was almost fully inhibited (P < 0.001, as compared to the effect of 
ghrelin, in the absence of verapamil; Figure 5E), although a residual K
+
-mediated [Ca
2+
]i rise 
could still be evidenced (P < 0.001, as compared to the effect of K
+
 in the absence of 
verapamil; Figure 5F). 
As we found that GHS-R1a stimulation produced a strong potentiation of the 
glutamatergic AMPA receptor-mediated synaptic transmission in hippocampal slices likely 
via postsynaptic mechanisms, we next evaluated whether GHS-R1a could directly modulate 
the activity of ionotropic glutamate receptors, i.e. AMPA/KA and NMDA receptors. In order 
to test this hypothesis, cells were pre-incubated for 30 min with 100 nM JMV1843 before the 
application of either kainate (20 µM) or NMDA (10 µM). Both ionotropic glutamate receptor 
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agonists induced a sustained increase in [Ca
2+
]i (P < 0.001, as compared to basal). 
Pretreatment with JMV1843 significantly enhanced kainate-mediated [Ca
2+
]i changes 
(F1,10448 = 21, P < 0.001; Figure 6A). Holm-Sidak post-hoc analysis indicated a significant 
difference (P < 0.0005) for data points obtained between time 2 and 3 min. Conversely, a 
similar pretreatment significantly decreased NMDA-elicited [Ca
2+
]i rises (F1,11248 = 134, P < 
0.001; Figure 6B), with a significant effect (P < 0.0005) for data points obtained between 
time 2 and 4 min.. This confirmed that ghrelin could modulate synaptic transmission by 
potentiating AMPA/KA receptor-associated physiological responses independently of 
NMDA receptor activation. 
 
DISCUSSION 
 
Recent studies showed that the orexigenic peptide ghrelin induced a strong modulation of 
hippocampal function which may be involved in the positive effect on cognition and learning 
mediated by hunger (Carlini et al., 2002; Diano et al., 2006; Olszewski et al., 2008; Andrews, 
2011; Davis et al., 2011). However, the mechanisms involved in this potentiation are not 
completely deciphered as ghrelin may activate a plethora of molecular mechanisms. Here, we 
show on rat hippocampal slices that ghrelin potently enhances synaptic transmission by 
activating PKA and ERK pathways. This effect of ghrelin results from the activation of GHS-
R1a, as evidenced with selective ligands, i.e. the agonist JMV1843 and the antagonist 
JMV2959. 
Ghrelin signaling in the hippocampus is often related to the induction of PKA pathway. 
Indeed, activation of PKA signaling occurred in organotypic hippocampal slices incubated 
with relatively higher concentrations of ghrelin (from 50 nM to 1 µM), as compared to those 
used herewith. This activation resulted in the phosphorylation of CREB, and in fine, in the 
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phosphorylation of the GluN1 subunit of the NMDA receptor (Cuellar & Isokawa, 2011). As 
far as long-term mechanisms of potentiation are concerned, we find here that the stimulation 
of both PKA and ERK pathways are critical steps in the ghrelin-induced long-lasting synaptic 
enhancement in the CA1 area of the hippocampus. It is known for long that PKA activation is 
crucial to trigger consolidated synaptic plasticity produced either electrically or chemically 
(Kandel, 2001). ERK phosphorylation downstream PKA activation is also required for the 
consolidation of synaptic plasticity in many experimental models as previously reported 
(Kanterewicz et al., 2000; Lynch, 2004; Sweatt, 2004). It is noticeable that activation of 
PI3Kinase-Akt signaling in the dentate gyrus may also stand for the occurrence of ghrelin-
evoked hippocampal synaptic plasticity (Chen et al., 2011), and also most likely for the 
enhancement of food-intake induced by intra-hippocampal infusion of ghrelin (Kanoski et al., 
2013). Thus our data further add to the complexity on the intracellular pathways activated by 
ghrelin in central neurons.  
 Contrasting results regarding the involvement of NMDA receptor activation in ghrelin-
mediated effects have been reported so far. In organotypic culture of hippocampal slices, 
NMDA receptor blockade actually inhibited the ghrelin-induced CREB activation (Cuellar & 
Isokawa, 2011), as well as AMPA receptor insertion (Ribeiro et al., 2014), suggesting that 
ghrelin could induce the potentiation of excitatory synaptic transmission via an enhancement 
of NMDA receptor activity. By contrast, in vivo, the ghrelin-mediated enhancement of 
excitatory synaptic transmission in the dentate gyrus was insensitive to NMDA receptor 
blockade (Chen et al., 2011). Using both acute hippocampal slice preparations and primary 
neuronal cultures, our data show an interaction between ghrelin-induced potentiation of 
excitatory synaptic transmission and NMDA receptor activation. Indeed, we firstly observed 
that NMDA receptor blockade enhanced the ghrelin-mediated synaptic potentiation in slices, 
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and secondly that ghrelin decreased the NMDA receptor-associated Ca
2+
 influx in primary 
hippocampal neuron cultures.  
The discrepancies in NMDA receptor dependency could be related to the experimental 
models used and/or to the metabolic environment of the neurons encountered in these 
preparations (Yang et al., 2011; Haam et al., 2014). Indeed, the effect of ghrelin on synaptic 
transmission in the hypothalamus is linked to the activity of the AMP activated kinase, a 
sensor for cellular metabolic status. Similarly, as reported in NPY-positive hypothalamic 
neurons, ghrelin-induced [Ca
2+
]i changes require AMP activated kinase activity (Kohno et 
al., 2008).  
On the other hand, we found that GHS-R1a activation reinforced AMPA receptor-
mediated responses in hippocampal neurons and that the paired-pulse facilitation ratio was 
unchanged after ghrelin treatment, consistent with the prominent recruitment of postsynaptic 
mechanisms for obtaining the enduring potentiation of synaptic transmission (Ribeiro et al., 
2014). Our data therefore support the possibility that ghrelin-induced potentiation relies upon 
an enhancement of AMPA receptor-mediated synaptic transmission by promoting the 
postsynaptic insertion of AMPA receptors. 
In the CA1 area of acute hippocampal slices, the ghrelin-induced long-lasting 
enhancement of synaptic transmission that we observe here is reminiscent of forms of long-
term potentiation independent of NMDA receptors and dependent on PKA activation, which 
have been identified in CA3 (Weisskopf et al., 1994) but also in CA1 (Lante et al., 2006; 
Lante et al., 2008) areas of the hippocampus, as well as in amygdala (Huang & Kandel, 
2007). 
The ghrelin-induced activation of PKA may initially result from an increase in [Ca
2+
]i and 
subsequent stimulation of Ca
2+
-dependent adenylyl cyclases (Chetkovich et al., 1991) to 
produce cAMP. Indeed, GHS-R1a may couple Gq (Mousseaux et al., 2006; Lau et al., 2009; 
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Sun et al., 2010) and subsequently activate PLC and mobilize Ca
2+
 from inositol-1,4,5-
trisphosphate (IP3)-sensitive stores (Camina et al., 2003; Falls et al., 2006). We verified that 
ghrelin and JMV1843 actually triggered increases in [Ca
2+
]i in hippocampal neurons. More 
precisely, we found here that [Ca
2+
]i changes elicited by GHS-R1a activation mainly resulted 
from influxes, as no [Ca
2+
]i changes could be observed in the absence of extracellular 
calcium. Moreover, we observe here that ghrelin-induced [Ca
2+
]i rises almost exclusively 
depend on L-type Ca
2+
 channels opening as evidenced by the strong inhibitory action of 
verapamil, a L-type Ca
2+
 channel blocker. Interestingly, the requirement of extracellular Ca
2+
 
for ghrelin to elicit [Ca
2+
]i increases and to produce its neurophysiological effects has also 
been evidenced in neuronal populations involved in food intake and neuroendocrine 
regulations. For instance, ghrelin induces [Ca
2+
]i increases dependent on both extracellular 
Ca
2+
 and PKA activation in Neuropeptide Y containing neurons of the arcuate nucleus of the 
hypothalamus (Kohno et al., 2008). Similarly, ghrelin triggers [Ca
2+
]i rises and growth 
hormone release in an extracellular Ca
2+
 dependent manner in goldfish pituitary cells (Grey 
& Chang, 2009). Thus, in these neuronal populations, ghrelin-associated signaling seems to 
mainly involve Ca
2+
 influxes through voltage-gated channels, rather than Ca
2+
 mobilization 
from internal stores. This is further supported by the fact that, in these experimental models, 
ghrelin-mediated [Ca
2+
]i rises are sensitive to N-type (Kohno et al., 2008) or L-type (Grey & 
Chang, 2009) Ca
2+
 channel blockade, respectively. Moreover, Ca
2+
 channel opening is 
required for observing excitatory effects of ghrelin on hypothalamic GHRH neurons 
(Osterstock et al., 2010). By contrast, blocking IP3 receptors with xestospongin-C does not 
seem to alter ghrelin-mediated CREB activation in CA1 hippocampal neurons (Cuellar & 
Isokawa, 2011).  
The intracellular Ca
2+
 changes elicited by ghrelin could thus result from the activation of 
voltage-gated Ca
2+
 channels subsequent to membrane depolarization. In this line, rapid 
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depolarizing responses to ghrelin have been observed in various neuronal subtypes, including 
substantia nigra, dorsal root ganglion and CA1 hippocampal (Shi et al., 2013), as well as 
cerebellar (Sun et al., 2014) neurons. Ghrelin enhances spike frequency likely by inhibiting 
voltage-gated K
+
 channels, as recently described in CA1 hippocampal neurons (Shi et al., 
2013). Therefore, long-lasting potentiation of excitatory synaptic transmission may be 
initiated by the depolarizing action of ghrelin, which leads to the activation of intracellular 
pathways resulting in the onset of consolidated enhancements of excitatory transmission. 
 
LEGENDS FOR THE FIGURES 
Figure 1: Action of ghrelin on CA1 synaptic transmission. (A) Long-lasting enhancement of 
excitatory synaptic transmission by ghrelin applied at 1, 10 or 100 nM for 20 min (n = 9 
each). Field EPSP were evoked in the CA1 area by stimulating the Schaffer collateral 
pathway and recorded with MEA. Graphs are illustrated by representative traces extracted 
before and after the application of ghrelin as indicated by numbers. (B) Paired-pulse 
facilitation ratio before and after the infusion of 100 nM ghrelin. Two pulses of stimulation 
were applied with 50 ms interval duration. Paired-pulse facilitation ratio was calculated by 
dividing the amplitude of the second fEPSP by the amplitude of the first one. On the graph, 
data are averages of paired-pulse ratios (± SEM) calculated from 5 independent experiments. 
Representative traces before and after the application of ghrelin are shown in the upper panel. 
 
Figure 2: Pharmacological characterization of the ghrelin action on excitatory transmission in 
the CA1 hippocampal area. (A) Effect of the specific GHS-R1a antagonist, JMV2959, on 
ghrelin-induced synaptic potentiation. JMV2959 (100 nM) was applied 10 min prior to 
ghrelin (10 nM for 20 min) and then maintained throughout the fEPSP recording (n = 7) 
Graphs are illustrated by representative traces extracted before and after the application of 
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ghrelin, as indicated by numbers. In the presence of JMV2959, ghrelin did not elicit any 
significant modification of synaptic transmission (P = 0.34, as compared to basal 
transmission). (B). Effect of the specific GHS-R1a agonist, JMV1843 (100 nM) on excitatory 
synaptic transmission (n = 9). Graphs are illustrated by representative traces extracted before 
and after the application of JMV1843 as indicated by numbers. 
 
Figure 3: Effect of ghrelin on synaptic transmission under NMDA receptor blockade. The 
specific NMDA receptor antagonist, AP5 (25 µM), was applied 10 min prior to ghrelin 
(10 nM for 20 min) and then maintained throughout the fEPSP recording (n = 9). Graphs are 
illustrated by representative traces extracted before and after the application of ghrelin, as 
indicated by numbers. 
 
Figure 4: Intracellular pathways involved in the ghrelin-mediated enduring synaptic 
potentiation. (A) Effect of PKA blockade with KT5720 (250 nM, n = 7). (B) Effect of the 
MEK inhibitor U0126 (10 µM, n = 7). Blockers were applied 10 min prior to ghrelin (10 nM 
for 20 min), and then maintained throughout the fEPSP recording. Per se, neither KT5720 
nor U0126 had any effect on basal synaptic transmission. 
 
Figure 5: Intracellular [Ca
2+
]i changes induced by either ghrelin or JMV1843 in cultured 
hippocampal neurons. (A, B) Concentration-dependent effects of ghrelin (n = 187 cells) (A) 
and JMV1843 (n = 207 cells) (B) on [Ca
2+
]i in the presence of Ca
2+
 in extracellular medium. 
(C, D) Effects of ghrelin (10 or 100 nM; n = 338 cells) and JMV1843 (300 nM; n = 258 
cells) on [Ca
2+
]i in the absence of Ca
2+
 in extracellular medium. Under these experimental 
conditions, DHPG (10 µM) application was performed as a positive control for intracellular 
Ca
2+
 mobilization. (E, F) Effect of L-type VGCC blocker verapamil (50 µM) on ghrelin-
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mediated [Ca
2+
]i rise. Control experiment (E) was performed by applying ghrelin (100 nM) 
and then K
+
 (30 mM) (n = 120 cells). Verapamil (F) was applied 2 min prior to ghrelin and 
K
+
 (n = 95 cells). Data presented in E and F was obtained from cells grown on different 
coverslips. Each drug was applied for 1 min at the indicated concentrations. 
 
Figure 6: Modulation of AMPA and NMDA receptor-mediated [Ca
2+
]i rises by JMV1843. 
[Ca
2+
]i changes mediated by either 20 µM kainate (A) or 10 µM NMDA (B) were measured 
in neurons pretreated (filled circles) or not (open circles) with the specific GHS-R1a agonist, 
JMV1843 (100 nM for 30 min). Glutamate receptor agonists were applied for 1 min. On the 
graphs, data obtained from pretreated cells have been superimposed with those obtained from 
their corresponding control cells without pretreatment. In (A) data are averages of ratios from 
257 and 101 cells for control and pretreated cultures, respectively. In (B) data are averages of 
ratios from 241 and 209 cells for control and pretreated cultures, respectively. Data have been 
normalized against the fura2 ratio measured in control cells prior to any treatment. * indicates 
P < 0.001 and ** indicates P < 0.0005 when comparing data from control vs pretreated cells.  
 
 
Acknowledgements: 
This work was supported by grants from CNRS and the French Ministry for Higher 
Education and Scientific Research. The authors have no conflict of interest of any kind to 
declare. 
A
cc
ep
te
d 
A
rt
ic
le
 
This article is protected by copyright. All rights reserved. 
References 
 
Andrews, Z.B. (2011) Central mechanisms involved in the orexigenic actions of ghrelin. 
Peptides, 32, 2248-2255. 
 
Atcha, Z., Chen, W.S., Ong, A.B., Wong, F.K., Neo, A., Browne, E.R., Witherington, J. & 
Pemberton, D.J. (2009) Cognitive enhancing effects of ghrelin receptor 
agonists. Psychopharmacology (Berl), 206, 415-427. 
 
Blanc, E.M., Jallageas, M., Recasens, M. & Guiramand, J. (1999) Potentiation of 
glutamatergic agonist-induced inositol phosphate formation by basic fibroblast 
growth factor is related to developmental features in hippocampal cultures: 
neuronal survival and glial cell proliferation. Eur J Neurosci, 11, 3377-3386. 
 
Camina, J.P., Carreira, M.C., Micic, D., Pombo, M., Kelestimur, F., Dieguez, C. & 
Casanueva, F.F. (2003) Regulation of ghrelin secretion and action. Endocrine, 
22, 5-12. 
 
Carlini, V.P., Monzon, M.E., Varas, M.M., Cragnolini, A.B., Schioth, H.B., Scimonelli, T.N. 
& de Barioglio, S.R. (2002) Ghrelin increases anxiety-like behavior and 
memory retention in rats. Biochem Biophys Res Commun, 299, 739-743. 
 
Carlini, V.P., Perez, M.F., Salde, E., Schioth, H.B., Ramirez, O.A. & de Barioglio, S.R. 
(2010) Ghrelin induced memory facilitation implicates nitric oxide synthase 
activation and decrease in the threshold to promote LTP in hippocampal 
dentate gyrus. Physiol Behav, 101, 117-123. 
 
Chen, L., Xing, T., Wang, M., Miao, Y., Tang, M., Chen, J., Li, G. & Ruan, D.Y. (2011) 
Local infusion of ghrelin enhanced hippocampal synaptic plasticity and spatial 
memory through activation of phosphoinositide 3-kinase in the dentate gyrus 
of adult rats. Eur J Neurosci, 33, 266-275. 
 
Chetkovich, D.M., Gray, R., Johnston, D. & Sweatt, J.D. (1991) N-methyl-D-aspartate 
receptor activation increases cAMP levels and voltage-gated Ca2+ channel 
activity in area CA1 of hippocampus. Proc Natl Acad Sci U S A, 88, 6467-
6471. 
 
Crouzin, N., Ferreira, M.C.D.J., Cohen-Solal, C., Aimar, R.F., Vignes, M. & Guiramand, J. 
(2007) alpha-Tocopherol-mediated long-lasting protection against oxidative 
damage involves an attenuation of calcium entry through TRP-like channels in 
cultured hippocampal neurons. Free Radic Biol Med, 42, 1326-1337. 
 
Cuellar, J.N. & Isokawa, M. (2011) Ghrelin-induced activation of cAMP signal transduction 
and its negative regulation by endocannabinoids in the hippocampus. 
Neuropharmacology, 60, 842-851. 
 
A
cc
ep
te
d 
A
rt
ic
le
 
This article is protected by copyright. All rights reserved. 
Davis, J.F., Choi, D.L., Clegg, D.J. & Benoit, S.C. (2011) Signaling through the ghrelin 
receptor modulates hippocampal function and meal anticipation in mice. 
Physiol Behav, 103, 39-43. 
 
de Jesus Ferreira, M.C., Crouzin, N., Barbanel, G., Cohen-Solal, C., Recasens, M., Vignes, 
M. & Guiramand, J. (2005) A transient treatment of hippocampal neurons with 
alpha-tocopherol induces a long-lasting protection against oxidative damage 
via a genomic action. Free Radic Biol Med, 39, 1009-1020. 
 
Diano, S., Farr, S.A., Benoit, S.C., McNay, E.C., da Silva, I., Horvath, B., Gaskin, F.S., 
Nonaka, N., Jaeger, L.B., Banks, W.A., Morley, J.E., Pinto, S., Sherwin, R.S., 
Xu, L., Yamada, K.A., Sleeman, M.W., Tschop, M.H. & Horvath, T.L. (2006) 
Ghrelin controls hippocampal spine synapse density and memory 
performance. Nat Neurosci, 9, 381-388. 
 
Dickson, S.L., Egecioglu, E., Landgren, S., Skibicka, K.P., Engel, J.A. & Jerlhag, E. (2011) 
The role of the central ghrelin system in reward from food and chemical drugs. 
Mol Cell Endocrinol, 340, 80-87. 
 
Falls, H.D., Dayton, B.D., Fry, D.G., Ogiela, C.A., Schaefer, V.G., Brodjian, S., Reilly, 
R.M., Collins, C.A. & Kaszubska, W. (2006) Characterization of ghrelin 
receptor activity in a rat pituitary cell line RC-4B/C. J Mol Endocrinol, 37, 51-
62. 
 
Goshadrou, F., Kermani, M., Ronaghi, A. & Sajjadi, S. (2013) The effect of ghrelin on MK-
801 induced memory impairment in rats. Peptides, 44, 60-65. 
 
Grey, C.L. & Chang, J.P. (2009) Ghrelin-induced growth hormone release from goldfish 
pituitary cells involves voltage-sensitive calcium channels. Gen Comp 
Endocrinol, 160, 148-157. 
 
Guan, X.M., Yu, H., Palyha, O.C., McKee, K.K., Feighner, S.D., Sirinathsinghji, D.J., Smith, 
R.G., Van der Ploeg, L.H. & Howard, A.D. (1997) Distribution of mRNA 
encoding the growth hormone secretagogue receptor in brain and peripheral 
tissues. Brain Res Mol Brain Res, 48, 23-29. 
 
Guerlavais, V., Boeglin, D., Mousseaux, D., Oiry, C., Heitz, A., Deghenghi, R., Locatelli, V., 
Torsello, A., Ghe, C., Catapano, F., Muccioli, G., Galleyrand, J.C., Fehrentz, 
J.A. & Martinez, J. (2003) New active series of growth hormone 
secretagogues. J Med Chem, 46, 1191-1203. 
 
Haam, J., Halmos, K.C., Di, S. & Tasker, J.G. (2014) Nutritional state-dependent ghrelin 
activation of vasopressin neurons via retrograde trans-neuronal-glial 
stimulation of excitatory GABA circuits. J Neurosci, 34, 6201-6213. 
 
Heuschkel, M.O., Fejtl, M., Raggenbass, M., Bertrand, D. & Renaud, P. (2002) A three-
dimensional multi-electrode array for multi-site stimulation and recording in 
acute brain slices. J Neurosci Methods, 114, 135-148. 
 
A
cc
ep
te
d 
A
rt
ic
le
 
This article is protected by copyright. All rights reserved. 
Huang, Y.Y. & Kandel, E.R. (2007) Low-frequency stimulation induces a pathway-specific 
late phase of LTP in the amygdala that is mediated by PKA and dependent on 
protein synthesis. Learn Mem, 14, 497-503. 
 
Isokawa, M. (2012) Cellular signal mechanisms of reward-related plasticity in the 
hippocampus. Neural Plast, 2012, 945373. 
 
Jerlhag, E., Egecioglu, E., Dickson, S.L., Andersson, M., Svensson, L. & Engel, J.A. (2006) 
Ghrelin stimulates locomotor activity and accumbal dopamine-overflow via 
central cholinergic systems in mice: implications for its involvement in brain 
reward. Addict Biol, 11, 45-54. 
 
Jerlhag, E., Janson, A.C., Waters, S. & Engel, J.A. (2012) Concomitant release of ventral 
tegmental acetylcholine and accumbal dopamine by ghrelin in rats. PLoS One, 
7, e49557. 
 
Jiang, H., Li, L.J., Wang, J. & Xie, J.X. (2008) Ghrelin antagonizes MPTP-induced 
neurotoxicity to the dopaminergic neurons in mouse substantia nigra. Exp 
Neurol, 212, 532-537. 
 
Kandel, E.R. (2001) The molecular biology of memory storage: a dialogue between genes 
and synapses. Science, 294, 1030-1038. 
 
Kanoski, S.E., Fortin, S.M., Ricks, K.M. & Grill, H.J. (2013) Ghrelin signaling in the ventral 
hippocampus stimulates learned and motivational aspects of feeding via PI3K-
Akt signaling. Biol Psychiatry, 73, 915-923. 
 
Kanterewicz, B.I., Urban, N.N., McMahon, D.B., Norman, E.D., Giffen, L.J., Favata, M.F., 
Scherle, P.A., Trzskos, J.M., Barrionuevo, G. & Klann, E. (2000) The 
extracellular signal-regulated kinase cascade is required for NMDA receptor-
independent LTP in area CA1 but not area CA3 of the hippocampus. J 
Neurosci, 20, 3057-3066. 
 
Kohno, D., Sone, H., Minokoshi, Y. & Yada, T. (2008) Ghrelin raises [Ca2+]i via AMPK in 
hypothalamic arcuate nucleus NPY neurons. Biochem Biophys Res Commun, 
366, 388-392. 
 
Lante, F., Cavalier, M., Cohen-Solal, C., Guiramand, J. & Vignes, M. (2006) Developmental 
switch from LTD to LTP in low frequency-induced plasticity. Hippocampus, 
16, 981-989. 
 
Lante, F., Crouzin, N. & Vignes, M. (2008) Unveiling novel forms of hippocampal synaptic 
plasticity with microelectrode arrays. J Integr Neurosci, 7, 249-270. 
 
Lau, P.N., Chow, K.B., Chan, C.B., Cheng, C.H. & Wise, H. (2009) The constitutive activity 
of the ghrelin receptor attenuates apoptosis via a protein kinase C-dependent 
pathway. Mol Cell Endocrinol, 299, 232-239. 
 
Lynch, M.A. (2004) Long-term potentiation and memory. Physiol Rev, 84, 87-136. 
 
A
cc
ep
te
d 
A
rt
ic
le
 
This article is protected by copyright. All rights reserved. 
Moon, M., Choi, J.G., Nam, D.W., Hong, H.S., Choi, Y.J., Oh, M.S. & Mook-Jung, I. (2011) 
Ghrelin ameliorates cognitive dysfunction and neurodegeneration in 
intrahippocampal amyloid-beta1-42 oligomer-injected mice. J Alzheimers Dis, 
23, 147-159. 
 
Moulin, A., Brunel, L., Boeglin, D., Demange, L., Ryan, J., M'Kadmi, C., Denoyelle, S., 
Martinez, J. & Fehrentz, J.A. (2013) The 1,2,4-triazole as a scaffold for the 
design of ghrelin receptor ligands: development of JMV 2959, a potent 
antagonist. Amino Acids, 44, 301-314. 
 
Moulin, A., Demange, L., Berge, G., Gagne, D., Ryan, J., Mousseaux, D., Heitz, A., 
Perrissoud, D., Locatelli, V., Torsello, A., Galleyrand, J.C., Fehrentz, J.A. & 
Martinez, J. (2007) Toward potent ghrelin receptor ligands based on 
trisubstituted 1,2,4-triazole structure. 2. Synthesis and pharmacological in 
vitro and in vivo evaluations. J Med Chem, 50, 5790-5806. 
 
Mousseaux, D., Le Gallic, L., Ryan, J., Oiry, C., Gagne, D., Fehrentz, J.A., Galleyrand, J.C. 
& Martinez, J. (2006) Regulation of ERK1/2 activity by ghrelin-activated 
growth hormone secretagogue receptor 1A involves a PLC/PKCvarepsilon 
pathway. Br J Pharmacol, 148, 350-365. 
 
Olszewski, P.K., Schioth, H.B. & Levine, A.S. (2008) Ghrelin in the CNS: from hunger to a 
rewarding and memorable meal? Brain Res Rev, 58, 160-170. 
 
Osterstock, G., Escobar, P., Mitutsova, V., Gouty-Colomer, L.A., Fontanaud, P., Molino, F., 
Fehrentz, J.A., Carmignac, D., Martinez, J., Guerineau, N.C., Robinson, I.C., 
Mollard, P. & Mery, P.F. (2010) Ghrelin stimulation of growth hormone-
releasing hormone neurons is direct in the arcuate nucleus. PLoS One, 5, 
e9159. 
 
Pantel, J., Legendre, M., Cabrol, S., Hilal, L., Hajaji, Y., Morisset, S., Nivot, S., Vie-Luton, 
M.P., Grouselle, D., de Kerdanet, M., Kadiri, A., Epelbaum, J., Le Bouc, Y. & 
Amselem, S. (2006) Loss of constitutive activity of the growth hormone 
secretagogue receptor in familial short stature. J Clin Invest, 116, 760-768. 
 
Pazos, Y., Casanueva, F.F. & Camiña, J.P. (2008) Basic Aspects of Ghrelin Action. Vitamins 
and hormones, 77, 89-119. 
 
Portelli, J., Thielemans, L., Ver Donck, L., Loyens, E., Coppens, J., Aourz, N., Aerssens, J., 
Vermoesen, K., Clinckers, R., Schallier, A., Michotte, Y., Moechars, D., 
Collingridge, G.L., Bortolotto, Z.A. & Smolders, I. (2012) Inactivation of the 
constitutively active ghrelin receptor attenuates limbic seizure activity in 
rodents. Neurotherapeutics, 9, 658-672. 
 
Pringos, E., Crouzin, N., Cavalier, M., Guiramand, J., Cohen-Solal, C., Martinez, J., Vignes, 
M. & Rolland, V. (2012) Synthesis and characterization of a cyclooctapeptide 
analogue of omega-agatoxin IVB enhancing the activity of Cav2.1 calcium 
channels activity in cultured hippocampal neurons. Neurochem Int, 61, 632-
639. 
 
A
cc
ep
te
d 
A
rt
ic
le
 
This article is protected by copyright. All rights reserved. 
Ribeiro, L.F., Catarino, T., Santos, S.D., Benoist, M., van Leeuwen, J.F., Esteban, J.A. & 
Carvalho, A.L. (2014) Ghrelin triggers the synaptic incorporation of AMPA 
receptors in the hippocampus. Proc Natl Acad Sci U S A, 111, E149-158. 
 
Shi, L., Bian, X., Qu, Z., Ma, Z., Zhou, Y., Wang, K., Jiang, H. & Xie, J. (2013) Peptide 
hormone ghrelin enhances neuronal excitability by inhibition of Kv7/KCNQ 
channels. Nature communications, 4, 1435. 
 
Sun, Q., Zang, W.J. & Chen, C. (2010) Growth hormone secretagogues reduce transient 
outward K+ current via phospholipase C/protein kinase C signaling pathway 
in rat ventricular myocytes. Endocrinology, 151, 1228-1235. 
 
Sun, Y., Shi, N., Li, H., Liu, K., Zhang, Y., Chen, W. & Sun, X. (2014) Ghrelin suppresses 
Purkinje neuron P-type Ca(2+) channels via growth hormone secretagogue 
type 1a receptor, the betagamma subunits of Go-protein, and protein kinase a 
pathway. Cell Signal, 26, 2530-2538. 
 
Sweatt, J.D. (2004) Mitogen-activated protein kinases in synaptic plasticity and memory. 
Curr Opin Neurobiol, 14, 311-317. 
 
Weisskopf, M.G., Castillo, P.E., Zalutsky, R.A. & Nicoll, R.A. (1994) Mediation of 
hippocampal mossy fiber long-term potentiation by cyclic AMP. Science, 265, 
1878-1882. 
 
Yang, Y.L., Atasoy, D., Su, H.H. & Sternson, S.M. (2011) Hunger States Switch a Flip-Flop 
Memory Circuit via a Synaptic AMPK-Dependent Positive Feedback Loop. 
Cell, 146, 991-1002. 
 
 
A
cc
ep
te
d 
A
rt
ic
le
 
This article is protected by copyright. All rights reserved. 
 
A
cc
ep
te
d 
A
rt
ic
le
 
This article is protected by copyright. All rights reserved. 
 
A
cc
ep
te
d 
A
rt
ic
le
 
This article is protected by copyright. All rights reserved. 
 
A
cc
ep
te
d 
A
rt
ic
le
 
This article is protected by copyright. All rights reserved. 
 
A
cc
ep
te
d 
A
rt
ic
le
 
This article is protected by copyright. All rights reserved. 
 
A
cc
ep
te
d 
A
rt
ic
le
 
This article is protected by copyright. All rights reserved. 
 
